Cybin Announces Closing of Overnight Marketed Public Offering of Common Shares and Exercise of Over-Allotment Option Post published:August 3, 2021 Post category:Press Release
MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology Post published:August 3, 2021 Post category:Press Release
Psychedelic Bulletin: MindMed Initiates DMT Trial; COMPASS Appoints CMO; Field Trip Lists on NASDAQ Post published:July 30, 2021 Post category:Psychedelic Bulletin
Red Light Holland Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements Post published:July 30, 2021 Post category:Press Release
Entheon Biomedical Corp. Acquires Lobo Genetics Inc. Post published:July 30, 2021 Post category:Press Release
Small Pharma Reports First Fiscal Quarter 2021 Highlights Post published:July 30, 2021 Post category:Press Release
Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing Post published:July 29, 2021 Post category:Press Release
Nova Mentis Files U.S. Patent Application for Psilocybin-Based Therapeutics Post published:July 29, 2021 Post category:Press Release
Levitee Labs Acquires Five Addiction Clinics in Alberta Post published:July 29, 2021 Post category:Press Release
Levitee Labs Acquires Three Specialized Alberta Pharmacies Post published:July 29, 2021 Post category:Press Release